Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and

Mamadou Kourna Hama1, Dam Khan2, Boubou Laouali1

  • 1Laboratoire Hopital National de Niamey, Niger.

Abstract

Insights

Meningitis remains a significant threat in Niger, with Streptococcus pneumoniae cases declining after PCV13 vaccine introduction. Neisseria meningitidis serogroup C is now the primary cause of meningococcal meningitis.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Meningitis is a prevalent infectious disease in Niger.
  • Key vaccines, including Haemophilus influenzae type b (Hib) and 13-valent pneumococcal conjugate vaccine (PCV13), were introduced in 2008 and 2014.
  • A vaccination campaign targeting Neisseria meningitidis serogroup A occurred in 2010-2011.

Purpose of the Study:

  • To evaluate changes in the distribution of bacterial meningitis pathogens in Niger.
  • To assess the impact of vaccination campaigns on meningitis epidemiology.
  • To analyze pathogen prevalence from 2010 to 2016.

Main Methods:

  • Hospital-based surveillance data from children under 5 years old with suspected meningitis were analyzed.
  • Cerebrospinal fluid (CSF) specimens were tested for vaccine-preventable bacterial pathogens.
  • Pathogen identification, serotyping/grouping, antimicrobial susceptibility testing, and whole genome sequencing were performed.

Main Results:

  • Bacterial meningitis was confirmed in 273 patients, with Neisseria meningitidis (48%) and Streptococcus pneumoniae (45%) being the most common pathogens.
  • A significant decrease in Streptococcus pneumoniae meningitis cases was observed post-PCV13 introduction (from 34 in 2014 to 16 in 2016).
  • Neisseria meningitidis serogroup C (NmC) was the predominant serogroup (59%) causing meningococcal meningitis.

Conclusions:

  • Neisseria meningitidis and Streptococcus pneumoniae continue to be major causes of meningitis in Niger.
  • The observed decline in S. pneumoniae meningitis following PCV13 vaccination is a positive development.
  • NmC is identified as the leading serogroup responsible for N. meningitidis meningitis in the region.

Related Concept Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Here, we describe a method to induce meningococcal meningitis through an intracisternal route of infection in adult mice. We present a step by step protocol of meningococcal infection from the preparation of inoculum to the intracisternal infection; then record the animal survival and evaluate the bacterial loads in murine...
7.6K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

The Quellung reaction is the gold standard technique for serotyping Streptococcus pneumoniae. This technique utilizes a microscope and specific pneumococcal antisera and is commonly used in reference and research laboratories...
46.5K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

The protocol described here highlights the major steps in the differentiating induced pluripotent stem-cell derived brain-like endothelial cells, the preparation of Neisseria meningitidis for infection, and sample collection for other molecular...
2.7K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Latex agglutination testing is a simple, rapid and inexpensive method for serotyping Streptococcus pneumoniae, and has also been widely applied in diagnostic microbiology. This manuscript describes the in-house production of latex agglutination reagents, quality control procedures and the application of this technique to pneumococcal...
22.6K
Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Experimental human pneumococcal carriage offers a natural model of carriage and a potential model for use in vaccine development. This technique is valuable yet complex and involves clinical risk by introducing a pathogen into a human. We have developed a detailed...
16.2K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

This paper describes a novel mouse model for the transition of pneumococcus from an asymptomatic colonizer to a disease-causing pathogen during viral infection. This model can be readily adapted to study polymicrobial and host-pathogen interactions during the different phases of disease progression and across various hosts.
3.1K